Clinical Study Manager

Overview

Clinical Study Manager

£50,000 - £55,000 plus benefits

Reports to: Senior Research Manager
Directorate: Research & Innovation
Contract: 24 month fixed-term contract
Hours: Full time 35 hours per week (Flexible working requests including 4-day weeks OR compressed hours will be considered)

Location: Stratford, London Office-based with high flexibility (1-2 days per week in the office). We’re happy to offer home-based contracts through our flexible working policy. While this role does involve occasional travel—typically 4 to 6 times a year within the London area—please note that travel expenses are not covered. We aim to keep travel minimal and purposeful, ensuring it adds real value to your work and team collaboration.

Please note: You must be eligible to work in the UK to apply for this vacancy. Cancer Research UK is not able to offer visa sponsorship.

Closing date: 1 February 2026 23:55
Recruitment process: Screening call followed by competency-based interview.
Interview date: Interviews will be held mid to late February

At Cancer Research UK, we exist to beat cancer.

Cancer Research UK are looking for a Clinical Study Manager to join our Center for Drug Development (CDD), leading the multidisciplinary clinical study teams to ensure all clinical trial deliverables are met. This is a 2-year contract to support our growing portfolio.

The CDD is the world's only charity-funded drug development facility. Our pioneering research is driven purely by the goal to see scientific breakthroughs bring benefits to patients sooner. CDD is the sponsor of early phase and precision medicine clinical trials in oncology agents. Our broad portfolio rivals that of a medium-sized pharmaceutical company, spanning antibodies, cell therapies, vaccines, drug conjugates and small molecules, making this an interesting and dynamic area to work in.

You might be a Clinical Study Manager /Trial Manager or Clinical Trial Project Manager, with experience working on Oncology trials (ideally early phase but not essential). You might have experience within the NHS, Pharma, Biotech or come from an academic background. Whatever the sector, if you can demonstrate relevant skills in managing clinical trials we would love to hear from you.

This is an opportunity to work as part of a multidisciplinary project team in a well-structured process driven environment. You’ll have the opportunity to be involved in various stages of clinical trials from set up, recruitment through to closedown.

• Ensure all trial deliverables are met according to timelines, budget, operational best practices and compliance with Cancer Research UK SOPs, policies, the EU Directive and ICH GCP guidelines

• To define and agree the study timelines and milestones in conjunction with the study team for their inclusion into the overall project plan

• To write and drive the preparation and review of the clinical study protocol and other study essential documents, according to the relevant SOPs

• To identify and assess potential trial sites with relevant members of the study team and decide on suitable sites for the study. To negotiate agreements with NHS trusts, including the negotiation of clinical trial costs

• To chair and facilitate study meetings with the internal teams, investigators and other key stakeholders and actively manage team actions, track study progress, and regularly communicate study progress to study team, Project Leader, Senior Research Manager and others as appropriate.

• To interact with Investigator sites and the study team to ensure excellence of study conduct, reviewing site performance, protocol deviations, and maintaining awareness of issues raised

• To liaise with the Medical Writing team for the delivery of the clinical study reports

• To identify best practices, lead or contribute to continual improvement initiatives and implement new procedures for managing clinical studies

• Biological Sciences degree or equivalent nursing qualification/experience

• Experience of managing clinical studies (preferably including early phase oncology) – evidence of successful adherence to study timelines and an understanding of key issues…